APVO Aptevo Therapeutics Inc. - Common Stock
$2,94
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 14, 2026
Zakres 52 tyg.
$1–$19
11% of range
Ocena Analityków
BUY
7 analysts
Cena Docelowa
$26
+767% upside
P/E (TTM)
-0.0
ROE
-217.2%
Marża Zysku Netto
—
APVO Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.94
Kapitalizacja Rynkowa
$3M
P/E (TTM)
-0.0
EPS (TTM)
$-87.27
Przychody (TTM)
—
Stopa dywidendy
—
ROE
-217.2%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $19
APVO Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
—
2016-12-31
→
2022-12-31
EPS
$-87.27
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2016-12-31
→
2022-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
APVO
Mediana porównawcza
P/E (TTM)
-0.0
—
P/S (TTM)
0.2
2.4
P/B
0.2
1.0
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
APVO
Mediana porównawcza
ROA
-121.4%
-105.1%
ROE
-217.2%
-142.1%
ROIC
-151.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
APVO
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
3.8
1.6
Quick Ratio (Wskaźnik Szybkości)
3.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
APVO
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
APVO
Mediana porównawcza
APVO Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
7 analityków
- Mocne kupno 2 28,6%
- Kup 4 57,1%
- Trzymaj 1 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
2 analityków · 2026-08-19
Mediana
$25.50
← Poniżej wszystkich celów
$2.94
Niski
$21.00
Wysoki
$30.00
Średni cel
$25.50
+767,3%
Średnia cel
$25.50
+767,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-4242.2%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-6.41 | $-5.71 | -0.70% |
| 31 grudnia 2025 | $-0.01 | $-8.25 | 8.2% |
| 30 września 2025 | $-33.48 | $-38.37 | 4.9% |
| 30 czerwca 2025 | $-151.20 | $-1527.55 | 1376.4% |
| 31 marca 2025 | $-1580.40 | $-1545.91 | -34.5% |
| 31 grudnia 2024 | $-29653.20 | $-2845.80 | -26807.4% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| BCAB | — | -0.6 | — | — | — | — |
| LABT | — | — | — | — | — | — |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| REVB | — | — | — | — | — | — |
| SBFM | — | — | — | — | — | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $3M | $12M | $4M | $32M | $23M | $15M | $10M | $34M | |
| Cost of Revenue | · | · | · | · | · | · | $20M | $11M | $5M | $12M | $17M | |
| R&D Expense | $15M | $14M | $17M | $18M | $19M | $18M | $25M | $35M | $29M | $29M | $35M | |
| SG&A Expense | $12M | $10M | $12M | $14M | $15M | $14M | $16M | $28M | $35M | $36M | $43M | |
| Operating Income | $-26M | $-25M | $-29M | $-29M | $-21M | $-27M | $-41M | $-52M | $-54M | $-139M | $-61M | |
| Other Non-op | $345.0K | $472.0K | $578.0K | $-4M | $-8M | $-1M | $-2M | $-2M | $-2M | $-810.0K | $-237.0K | |
| Pretax Income | $-26M | $-24M | $-19M | $7M | $-29M | $-31M | $-43M | $-54M | $-56M | $-140M | $-61M | |
| Income Tax | $0 | · | · | · | · | · | · | · | $-23M | $-20M | $-2M | |
| Net Income | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | $-59M | |
| EPS (Basic) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| EPS (Diluted) | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 | · | · | · | · | · | · | |
| Shares (Basic) | 315,535 | 767 | 7,515 | 5,100,310 | 4,687,952 | · | · | · | · | · | · | |
| Shares (Diluted) | 315,535 | 767 | 7,515 | 5,102,914 | 4,687,952 | · | · | · | · | · | · | |
| EBITDA | $-26M | $-24M | $-28M | $-28M | $-20M | · | $-40M | $-49M | · | $-124M | · |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $9M | $17M | $23M | $45M | $40M | $12M | $31M | $7M | $10M | $5M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $74M | $45M | · | |
| Receivables | · | · | · | · | · | · | $7M | $5M | $2M | $307.0K | $6M | |
| Inventory | · | · | · | · | · | · | $6M | $2M | $1M | $461.0K | $20M | |
| Prepaid Expense | $1M | $2M | $1M | $2M | $2M | $2M | $1M | $7M | $4M | $6M | $2M | |
| Other Current Assets | $853.0K | $1M | $689.0K | $744.0K | $780.0K | $133.0K | $160.0K | $4M | $7M | $2M | · | |
| Current Assets | $23M | $11M | $19M | $27M | $53M | $47M | $30M | $49M | $95M | $71M | $35M | |
| PP&E (Net) | $303.0K | $543.0K | $895.0K | $1M | $2M | $3M | $4M | $5M | $6M | $6M | $4M | |
| PP&E (Gross) | $14M | $14M | $14M | $14M | $15M | $14M | $14M | $14M | $13M | $13M | $10M | |
| Accum. Depreciation | $14M | $14M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | $29M | |
| Intangibles | · | · | · | · | · | · | $4M | $5M | $6M | $7M | · | |
| Other Non-current Assets | · | · | · | · | $68.0K | $746.0K | $757.0K | $905.0K | · | · | · | |
| Total Assets | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Accounts Payable | $877.0K | $1M | · | · | · | · | $6M | $12M | · | · | $10M | |
| Current Liabilities | $6M | $6M | $7M | $9M | $35M | $15M | $38M | $18M | $19M | $20M | $20M | |
| Capital Leases | $4M | $5M | $5M | $6M | $1M | $2M | $3M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $16M | |
| Other Non-current Liabilities | · | $0 | · | · | · | · | · | $200.0K | $734.0K | $469.0K | $71.0K | |
| Total Liabilities | $10M | $11M | $13M | $16M | $55M | $37M | $42M | $37M | $35M | $41M | $39M | |
| Long-term Debt | · | · | $0 | $4M | $16M | $28M | · | · | $19M | · | · | |
| Total Debt | · | · | · | $3M | $12M | · | $20M | $19M | · | $18M | · | |
| Common Stock | $114.0K | $84.0K | $61.0K | $48.0K | $47.0K | $46.0K | $45.0K | $23.0K | $22.0K | $20.0K | · | |
| Retained Earnings | $-275M | $-248M | $-223M | $-206M | $-214M | $-186M | $-168M | $-127M | $-74M | $-81M | $-232M | |
| AOCI | · | · | · | · | · | · | · | · | $-105.0K | $-33.0K | · | |
| Stockholders' Equity | $17M | $5M | $12M | $18M | $1M | $17M | $12M | $30M | $82M | $51M | $89M | |
| Liabilities + Equity | $27M | $16M | $25M | $34M | $57M | $54M | $53M | $67M | $117M | $92M | $128M | |
| Shares Outstanding | 997,830 | 4,051 | 11,958 | 6,466,294 | 4,898,143 | 4,410,909 | 3,234,231 | 22,808,416 | 21,605,716 | 20,271,737 | 0 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $240.0K | $352.0K | $567.0K | $901.0K | $1M | $1M | $2M | $2M | $3M | $3M | $3M | |
| Stock-based Comp | $96.0K | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $5M | $4M | $1M | |
| Deferred Tax | · | · | · | · | · | · | · | · | $-11M | $-15M | $-1M | |
| Amort. of Intangibles | · | · | · | · | · | · | $800.0K | $800.0K | $800.0K | $800.0K | $3M | |
| Other Non-cash | $39.0K | $-1M | $3M | $-32M | $4M | · | $-6M | $-2M | · | $84M | · | |
| Operating Cash Flow | $-26M | $-24M | $-12M | $-21M | $-22M | $-29M | $-42M | $-51M | $-42M | $-37M | $-49M | |
| CapEx | · | · | · | $29.0K | $713.0K | $88.0K | $153.0K | $976.0K | $1M | $3M | $2M | |
| Investing Cash Flow | $0 | $0 | $0 | $-29.0K | $-713.0K | $28M | $4M | $73M | $29M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $20M | · | |
| Net Debt Issued | · | $0 | $-3M | $-12M | $-11M | · | · | · | · | $20M | · | |
| Stock Issued | $38M | $10M | $6M | $7M | $10M | · | · | $623.0K | $442.0K | · | · | |
| Net Stock Activity | $38M | $10M | · | $7M | $10M | · | · | $623.0K | · | · | · | |
| Financing Cash Flow | $38M | $16M | $6M | $-3M | $26M | $24M | $20M | $-787.0K | $20M | · | · | |
| Net Change in Cash | $13M | $-8M | $-6M | $-24M | $4M | $23M | $-18M | $21M | $7M | $5M | $1M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-21M | $-22M | · | $-43M | $-52M | · | $-39M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -919.8% | -174.1% | · | -131.4% | -224.0% | · | -348.4% | · | |
| Net Margin | · | · | · | 257.8% | -231.5% | · | -124.8% | -232.8% | · | -308.5% | · | |
| Pretax Margin | · | · | · | 225.2% | -239.2% | · | -137.8% | -232.8% | · | -350.6% | · | |
| EBITDA Margin | · | · | · | -890.8% | -164.8% | · | -124.5% | -213.6% | · | -339.2% | · | |
| ROA | -121.4% | -119.4% | -59.0% | 17.7% | -51.7% | · | -66.9% | -58.2% | · | -99.8% | · | |
| ROE | -217.2% | -526.0% | -129.3% | 47.6% | -668.9% | · | -256.1% | -144.3% | · | -152.2% | · | |
| ROIC | -151.4% | · | · | · | · | · | · | · | · | -162.0% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 | · | 0.8 | 2.8 | · | 3.7 | · | |
| Quick Ratio | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 | · | 0.5 | 2.0 | · | 3.0 | · | |
| Debt / Equity | · | · | · | 0.2 | 9.6 | · | 1.7 | 0.6 | · | 0.4 | · | |
| LT Debt / Equity | · | · | · | 0.1 | · | · | · | 0.6 | · | 0.4 | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.1 | 0.2 | · | 0.5 | 0.2 | · | 0.3 | · | |
| Inventory Turnover | · | · | · | · | · | · | 5.0 | · | · | 1.8 | · | |
| Receivables Turnover | · | · | · | · | · | · | 5.3 | 6.3 | · | 6.8 | · |
Stopy Wzrostu 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -74.7% | 185.3% | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | $12M | $3M | $12M | $4M | $32M | $23M | $15M | $10M | · | |
| Net Income TTM | $-26M | $-24M | $-17M | $8M | $-28M | $-18M | $-40M | $-54M | $7M | $-112M | · | |
| Market Cap | $9M | $126M | $114.73B | $488.46B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| Enterprise Value | · | · | · | $488.44B | $1.26T | · | $13.52T | $13.20T | · | $22.55T | · | |
| P/E | -0.1 | -0.0 | -2.5 | 48114.1 | -42215.4 | · | · | · | · | · | · | |
| P/S | 0.8 | 10.7 | 9772.0 | 156858.9 | 102109.9 | · | 416952.2 | 572427.1 | · | 2258110.4 | · | |
| P/B | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | · | 1141636.4 | 434262.2 | · | 445897.1 | · | |
| P / Tangible Book | 0.5 | 26.4 | 9388.2 | 27175.8 | 1032183.8 | 317201.6 | · | · | · | · | · | |
| P / Cash Flow | -0.4 | -5.3 | -9781.2 | -23235.6 | -57896.4 | · | -318978.3 | -256780.7 | · | -611666.0 | · | |
| P / FCF | · | · | · | -23203.6 | -56052.9 | · | -317831.0 | -251997.7 | · | -572642.7 | · | |
| EV / EBITDA | · | · | · | -17607.8 | -61962.0 | · | -334958.7 | -267968.8 | · | -182445.8 | · | |
| EV / FCF | · | · | · | -23202.7 | -56051.4 | · | -317831.2 | -251997.5 | · | -572641.7 | · | |
| EV / Revenue | · | · | · | 156852.8 | 102107.2 | · | 416952.4 | 572426.6 | · | 2258106.7 | · | |
| Earnings Yield | -925.5% | -36496.8% | -39.3% | 0.00% | 0.00% | · | · | · | · | · | · |
Rachunek zysków i strat 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $4M | $4M | $4M | $4M | $3M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | $5M | $4M | $5M | $4M | |
| SG&A Expense | $3M | $3M | $2M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-7M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $87.0K | $140.0K | $190.0K | $61.0K | $22.0K | $72.0K | $70.0K | $112.0K | $141.0K | $149.0K | $188.0K | $227.0K | $230.0K | $-67.0K | $21.0K | $-25.0K | |
| Net Income | $-6M | $-7M | $-6M | $-8M | $-6M | $-6M | $-6M | $-5M | $-6M | $-7M | $-6M | $-6M | $-8M | $3M | $-5M | $-8M | |
| EPS (Basic) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| EPS (Diluted) | $-5.31 | $-6.41 | $-72.25 | $-2.23 | $-151.29 | $-1581.81 | $-29497.20 | $-357.86 | $-1236.96 | $-368.21 | $-2258.10 | $-22.16 | $-53.95 | $17.38 | $-0.96 | $-1.50 | |
| Shares (Basic) | 1,196,364 | 1,060,678 | -5,930,118 | 4,049,046 | 41,008 | 4,051 | -36,803 | 14,254 | 4,756 | 18,560 | -585,289 | 285,886 | 147,321 | 159,597 | -9,951,059 | 5,090,592 | |
| Shares (Diluted) | 1,196,364 | 1,060,678 | -5,930,118 | 4,049,046 | 41,008 | 4,051 | -36,803 | 14,254 | 4,756 | 18,560 | -585,289 | 285,886 | 147,321 | 159,597 | -9,948,455 | 5,090,592 | |
| EBITDA | $-6M | · | · | $-8M | $-6M | $-6M | · | $-5M | $-6M | $-7M | · | $-7M | $-8M | $-8M | · | $-8M |
Bilans 20
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $15M | $22M | $21M | $9M | $2M | $9M | $8M | $8M | $10M | $17M | $19M | $21M | $25M | $23M | $22M | |
| Prepaid Expense | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $798.0K | $1M | $1M | $1M | $910.0K | $2M | $2M | $1M | |
| Other Current Assets | $462.0K | $851.0K | $853.0K | $77.0K | $82.0K | $120.0K | $1M | $624.0K | $715.0K | $691.0K | $689.0K | $649.0K | $764.0K | $2M | $744.0K | $658.0K | |
| Current Assets | $11M | $16M | $23M | $23M | $11M | $4M | $11M | $10M | $10M | $12M | $19M | $21M | $23M | $28M | $27M | $25M | |
| PP&E (Net) | $236.0K | $268.0K | $303.0K | $384.0K | $432.0K | $482.0K | $543.0K | $614.0K | $697.0K | $789.0K | $895.0K | $1M | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | |
| Accum. Depreciation | · | · | $14M | · | · | · | $14M | · | · | · | $14M | · | · | · | $13M | · | |
| Total Assets | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Accounts Payable | $1M | $890.0K | $877.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $5M | $5M | $6M | $6M | $5M | $5M | $6M | $6M | $5M | $6M | $7M | $7M | $7M | $6M | $9M | $8M | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $6M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $14.0K | $14.0K | $14.0K | · | · | · | · | · | · | |
| Total Liabilities | $8M | $8M | $10M | $10M | $9M | $10M | $11M | $11M | $10M | $12M | $13M | $12M | $13M | $12M | $16M | $16M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $3M | $4M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Common Stock | $114.0K | $114.0K | $114.0K | $110.0K | $99.0K | $84.0K | $84.0K | $82.0K | $69.0K | $66.0K | $61.0K | $56.0K | $49.0K | $49.0K | $48.0K | $47.0K | |
| Retained Earnings | $-288M | $-282M | $-275M | $-269M | $-260M | $-254M | $-248M | $-241M | $-236M | $-230M | $-223M | $-218M | $-211M | $-203M | $-206M | $-201M | |
| Stockholders' Equity | $6M | $12M | $17M | $17M | $7M | $-1M | $5M | $4M | $4M | $6M | $12M | $15M | $16M | $23M | $18M | $16M | |
| Liabilities + Equity | $15M | $20M | $27M | $27M | $16M | $8M | $16M | $15M | $15M | $18M | $25M | $27M | $29M | $35M | $34M | $32M | |
| Shares Outstanding | 1,418,952 | 1,203,753 | 997,830 | 13,808,966 | 3,224,156 | 1,458,504 | 4,051 | 17,050,536 | 4,080,665 | 673,430 | 11,958 | 14,465,703 | 7,543,440 | 7,239,471 | 6,466,294 | 5,090,644 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $32.0K | $35.0K | $81.0K | $49.0K | $49.0K | $61.0K | $71.0K | $84.0K | $91.0K | $106.0K | $116.0K | $123.0K | $150.0K | $178.0K | $161.0K | $222.0K | |
| Stock-based Comp | $58.0K | $57.0K | $2.0K | $77.0K | $-163.0K | $180.0K | $-72.0K | $149.0K | $273.0K | $719.0K | $358.0K | $455.0K | $465.0K | $915.0K | $357.0K | $359.0K | |
| Other Non-cash | · | · | · | · | · | $-408.0K | · | · | · | $-642.0K | · | · | · | $700.0K | · | · | |
| Operating Cash Flow | $-5M | $-8M | $-5M | $-7M | $-7M | $-7M | $-6M | $-5M | $-6M | $-7M | $-5M | $-6M | $-5M | $5M | $-6M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $4.0K | |
| Investing Cash Flow | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | $0 | $-4.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-3M | · | · | |
| Stock Issued | $726.0K | $872.0K | $32M | $-9M | $14M | $0 | · | $6M | · | · | $3M | $1M | $481.0K | $2M | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $6M | · | · | · | · | · | $2M | · | · | |
| Financing Cash Flow | $726.0K | $871.0K | $6M | $18M | $14M | $0 | $7M | $5M | $4M | $-3.0K | $3M | $4M | $481.0K | $-2M | $6M | $-500.0K | |
| Net Change in Cash | $-5M | $-7M | $558.0K | $12M | $7M | $-7M | $961.0K | $-313.0K | $-2M | $-7M | $-2M | $-2M | $-4M | $3M | $59.0K | $-7M |
Rentowność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -42.2% | · | · | -35.8% | -40.6% | -49.4% | · | -24.1% | -26.8% | -26.0% | · | -21.5% | -23.5% | 6.9% | · | -16.0% | |
| ROE | -101.2% | · | · | -69.2% | -112.9% | -276.8% | · | -53.3% | -56.8% | -46.6% | · | -41.6% | -40.5% | 31.9% | · | -66.3% |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | · | · | 4.0 | 2.3 | 0.7 | · | 1.7 | 1.8 | 1.9 | · | 3.1 | 3.3 | 4.9 | · | 3.2 | |
| Quick Ratio | 1.9 | · | · | 3.8 | 1.9 | 0.4 | · | 1.3 | 1.5 | 1.6 | · | 2.8 | 3.0 | 4.4 | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Wycena (TTM) 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12M | $12M | · | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | $12M | $12M | · | $12M | |
| Net Income TTM | $-27M | $-27M | · | $-25M | $-24M | $-24M | · | $-24M | $-27M | $-18M | · | $-19M | $15M | $15M | · | $6M | |
| Market Cap | $6M | · | · | $20M | $10M | $34M | · | $2.27B | $924M | $2.34B | · | $155.43B | $358.60B | $479.68B | · | $503.88B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $503.87B | |
| P/E | -0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | -0.1 | -0.1 | -8.1 | · | -178.4 | -1463.1 | 3328.0 | · | 89984.0 | |
| P/S | 0.5 | · | · | 1.7 | 0.8 | 2.9 | · | 193.4 | 78.7 | 199.1 | · | 13238.3 | 30542.3 | 40855.5 | · | 42916.6 | |
| P/B | 1.0 | · | · | 1.2 | 1.5 | -23.0 | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Tangible Book | 1.0 | 0.4 | · | 1.2 | 1.5 | · | · | 513.8 | 207.0 | 383.0 | · | 10560.6 | 22063.4 | 20626.3 | · | 31968.3 | |
| P / Cash Flow | · | · | · | · | · | -5.1 | · | · | · | -351.4 | · | · | · | 105055.7 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -64731.0 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 42915.1 | |
| Earnings Yield | -3721.6% | -37443.8% | · | -25715.9% | -52708.5% | -8480.3% | · | -1490.4% | -742.5% | -12.3% | · | -0.56% | -0.07% | 0.03% | · | 0.00% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | — | — | — | $3M | $12M |
| Marża Operacyjna % | — | — | — | -919.8% | -174.1% |
| Zysk netto | $-26M | $-24M | $-17M | $8M | $-28M |
| Rozwodniony EPS | $-87.27 | $-31460.23 | $-2316.83 | $1.57 | $-6.07 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | — | 0.2 | 9.6 |
| Wskaźnik bieżący | 3.8 | 1.7 | 2.6 | 3.2 | 1.5 |
| Wskaźnik Szybkości | 3.6 | 1.4 | 2.3 | 2.6 | 1.3 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | — | $-21M | $-22M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 11 emitentów · $152K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 3 (-1 vs poprzedni kw.) | 0 (-4 vs poprzedni kw.) | 1 (-1 vs poprzedni kw.) | 2 (+1 vs poprzedni kw.) | -4K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $56 446 | 12 713 | 37,24% | Akcje |
| VANGUARD GROUP INC | $39 059 | 4 142 | 25,77% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $35 222 | 7 933 | 23,24% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $18 390 | 4 142 | 12,13% | Akcje |
| OSAIC HOLDINGS, INC. | $1 596 | 360 | 1,05% | Akcje |
| SBI Securities Co., Ltd. | $484 | 109 | 0,32% | Akcje |
| BARCLAYS PLC | $138 | 31 | 0,09% | Akcje |
| UBS Group AG | $98 | 22 | 0,06% | Akcje |
| GSA CAPITAL PARTNERS LLP | $96 | 21 539 | 0,06% | Akcje |
| CWM, LLC | $21 | 5 | 0,01% | Akcje |
| DANSKE BANK A/S | $4 | 1 | 0,00% | Akcje |
Insiderzy spółki 17 insiderów · 5 dyrektorzy generalni · 1 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jane A Gross | SVP & Chief Scientific Officer | 29 stycznia 2021 A | 109 583 | 0 | 0 | $0 |
| Randy Joe Maddux | SVP of Operations, CMO | 27 lipca 2020 A | 75 000 | 0 | 0 | $0 |
| Michael Adelman | SVP, Commercial Operations | 18 lutego 2020 A | 70 426 | 0 | 0 | $0 |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | 18 lutego 2020 A | 80 527 | 0 | 0 | $0 |
| Scott C Stromatt | Chief Medical Officer and SVP | 1 marca 2019 M | 216 183 | 0 | 0 | $0 |
| Fuad El-Hibri | Dyrektor | 3 grudnia 2021 J | 7 373 | 0 | 0 | $0 |
| Emergent BioSolutions Inc. | Posiadacz 10% | 1 sierpnia 2016 J | 0 | 0 | 0 | $0 |
| Soyoung Kwon | — | 6 sierpnia 2026 M | 638 | 0 | 0 | $0 |
| Dirk Huebner | — | 6 sierpnia 2026 M | 482 | 0 | 0 | $0 |
| Barbara Lopez Kunz | — | 6 sierpnia 2026 M | 400 | 0 | 0 | $0 |
| Jeffrey G. Lamothe | — | 6 sierpnia 2026 M | 961 | 0 | 0 | $0 |
| Grady Grant III | — | 6 sierpnia 2026 M | 1 150 | 1 | 0 | $20 134 |
| John Niederhuber | — | 6 sierpnia 2026 M | 400 | 0 | 0 | $0 |
| Marvin L White | — | 6 sierpnia 2026 M | 1 261 | 0 | 0 | $0 |
| Daphne Taylor | — | 6 sierpnia 2026 M | 638 | 0 | 0 | $0 |
| Daniel Abdun-Nabi | — | 6 sierpnia 2026 M | 400 | 0 | 0 | $0 |
| Zsolt Harsanyi | — | 6 sierpnia 2026 M | 400 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×6 zgłoszenia | 26 listopada 2021 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 3 sierpnia 2016 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 lipca 2026 | Dziennie |